IGC Pharma
23 hedge funds and large institutions have $900K invested in IGC Pharma in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 26 → 23 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
23
Holding in Top 10
–
Calls
$53K
Puts
$10K
Top Buyers
| 1 | +$3.87K | |
| 2 | +$3.6K | |
| 3 | +$3.59K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.73K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7 |
Top Sellers
| 1 | -$37.5K | |
| 2 | -$21K | |
| 3 | -$13.8K | |
| 4 |
Jane Street
New York
|
-$7.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$7.15K |